Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Cetyl Palmitate-based NLC For Topical Delivery Of Coenzyme Q(10) - Development, Physicochemical Characterization And In Vitro Release Studies.

Veerawat Teeranachaideekul, E. Souto, V. Junyaprasert, R. Mueller
Published 2007 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In the present study, nanostructured lipid carriers (NLC) composed of cetyl palmitate with various amounts of caprylic/capric triacylglycerols (as liquid lipid) were prepared and Coenzyme Q(10) (Q(10)) has been incorporated in such carriers due to its high lipophilic character. A nanoemulsion composed solely of liquid lipid was prepared for comparison studies. By photon correlation spectroscopy a mean particle size in the range of 180-240nm with a narrow polydispersity index (PI) lower than 0.2 was obtained for all developed formulations. The entrapment efficiency was 100% in all cases. The increase of oil loading did not affect the mean particle size of NLC formulations. NLC and nanoemulsion, stabilized by the same emulsifier, showed zeta potential values in the range -40/-50mV providing a good physical stability of the formulations. Scanning electron microscopy studies revealed NLC of disc-like shape. With respect to lipid polymorphism, a decrease in the ordered structure of NLC was observed with the increase of both oil and Q(10) loadings, allowing therefore high accommodation for Q(10) within the NLC. Using static Franz diffusion cells, the in vitro release studies demonstrated that Q(10)-loaded NLC possessed a biphasic release pattern, in comparison to Q(10)-loaded nanoemulsions comprising similar composition of which a nearly constant release was observed. The NLC release patterns were defined by an initial fast release in comparison to the release of NE followed by a prolonged release, which was dependent on the oil content.
This paper references
10.1016/S0009-2509(00)00458-9
Crystallization behaviour of fats and lipids — a review
K. Sato (2001)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
Anne Saupe (2005)
10.1002/BIOF.5520090238
Coenzyme Q10, a cutaneous antioxidant and energizer
U. Hoppe (1999)
10.1080/02652040010000361
Encapsulation of retinoids in solid lipid nanoparticles (SLN).
V. Jenning (2001)
10.1016/S0142-9612(02)00578-1
The production and characteristics of solid lipid nanoparticles (SLNs).
DongZhi Hou (2003)
10.1016/J.JCONREL.2004.06.015
Skin penetration and distribution of polymeric nanoparticles.
R. Alvarez-Román (2004)
10.1016/J.JCONREL.2003.11.012
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
K. Jores (2004)
10.1016/J.BIOPHA.2004.02.001
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
R. N. Gursoy (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/S0939-6411(98)00074-5
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
C. Freitas (1999)
10.1080/02652040500162436
SLN and NLC for topical delivery of ketoconazole
E. Souto (2005)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/J.IJPHARM.2004.02.032
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
E. Souto (2004)
10.1016/S0378-5173(99)00426-3
Comparison of wax and glyceride solid lipid nanoparticles (SLN).
V. Jenning (2000)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1007/s003969900257
Novel lipid-based colloidal dispersions as potential drug administration systems – expectations and reality
K. Westesen (2000)
10.1016/J.COLSURFB.2005.08.005
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
F. Hu (2005)
10.1208/pt040332
Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors
Cheng-Hsuan Hsu (2008)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1016/S0378-5173(99)00421-4
Crystallographic investigation of cetylpalmitate solid lipid nanoparticles.
G. Lukowski (2000)
10.1016/S0378-5173(97)00311-6
Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique
R. Mueller (1998)
10.1016/0378-5173(93)90177-H
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1016/J.IJPHARM.2006.01.022
Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
A. Saupe (2006)
10.1016/S0168-3659(02)00056-1
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration.
S. Wissing (2002)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)



This paper is referenced by
10.4028/www.scientific.net/AMR.345.53
Preparation and Characterization of Coenzyme Q10 Powder Micronized by a Rapid Expansion of Supercritical Solution (RESS) Process
X. D. Meng (2011)
10.1016/J.APCATB.2012.10.018
Preparation of Cu2(OH)3NO3/ZnO, a novel catalyst for methyl orange oxidation under ambient conditions
Assadawoot Srikhaow (2013)
10.1016/J.JFOODENG.2015.10.005
Compound release from nanostructured lipid carriers (NLCs)
N. Dan (2016)
10.1016/j.ijpharm.2015.07.036
A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Q. Luo (2015)
Preparation and Evaluation of Darifenacin Hydrobromide Loaded Nanostructured Lipid Carriers for Oral Administration
A. K. A. Allah (2018)
10.1111/j.1468-2494.2010.00626.x
Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone‐3
S. P. Lacerda (2011)
10.1016/j.ijpharm.2008.10.003
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
Preparation and Optimization of Nanoemulsions for targeting Drug Delivery
N. Sharma (2014)
10.2147/IJN.S34921
A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers
E. Gokce (2012)
10.1155/2015/263131
Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)
W. K. Ng (2015)
10.1016/S1773-2247(14)50124-4
Lipid based nanocarriers with different lipid compositions for topical delivery of resveratrol: comparative analysis of characteristics and performance
R. Sun (2014)
10.1016/J.PMATSCI.2011.10.001
Current status and future prospects of nanotechnology in cosmetics
A. Mihranyan (2012)
10.1016/j.molliq.2020.113040
A way to introducing a hydrophilic bioactive agent into model lipid membranes. The role of cetyl palmitate in the interaction of curcumin with 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine monolayers
M. Girardon (2020)
An investigation into the feasibility of incorporating didanosine into innovative solid lipid nanocarriers
K. W. Kasongo (2010)
Preparation and Characterization of Fatty Acid Nanocarriers
J. Woo (2012)
10.1155/2014/345845
Hyaluronate Targeted Solid Lipid Nanoparticles of Etoposide: Optimization and In Vitro Characterization
J. Varshosaz (2014)
10.1111/php.12117
Coencapsulation of Butyl‐Methoxydibenzoylmethane and Octocrylene into Lipid Nanocarriers: UV Performance, Photostability and in vitro Release
G. Niculae (2013)
10.1021/jf4003297
Enhanced water dispersibility of coenzyme Q10 by complexation with albumin hydrolysate.
Nao Matsushita (2013)
10.2174/1381612821666150428124053
Overcoming the skin permeation barrier: challenges and opportunities.
C. Vitorino (2015)
10.3109/10837450.2011.614251
In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate
G. Abdelbary (2013)
10.1016/j.jsps.2019.08.004
Development of solid dispersion lipid nanoparticles for improving skin delivery
Duong T.T. Pham (2019)
10.5650/jos.ess17113
Development of γ-Oryzanol Rich Extract from Leum Pua Glutinous Rice Bran Loaded Nanostructured Lipid Carriers for Topical Delivery.
W. Pornputtapitak (2018)
10.1080/02652048.2020.1761904
Development of folic acid–loaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation
H. Ammar (2020)
10.1504/IJBNN.2012.051218
Development of nanostructured lipid carriers for controlled delivery of mefenamic acid
S. Khurana (2012)
10.1016/j.ijpharm.2014.10.004
Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
P. Nnamani (2014)
10.1016/j.ijpharm.2015.08.026
Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles.
V. S. Gonçalves (2015)
10.1007/978-3-319-11355-5_13
Functionalized Lipid Particulates in Targeted Drug Delivery
M. Nagarsenker (2015)
10.1016/j.colsurfb.2015.09.040
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery.
F. Sacchetti (2015)
10.1007/s13346-016-0317-8
Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line
P. Singh (2016)
10.19044/ESJ.2013.V9N21P%P
SOLID LIPID NANOPARTICLES FOR TOPICAL DELIVERY OF MELOXICAM: DEVELOPMENT AND IN VITRO CHARACTERIZATION
R. Khalil (2013)
10.2147/IJN.S16815
Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies
E. Farboud (2011)
10.2147/IJN.S215835
Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design
Minhwan Kim (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar